{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:38:04Z","timestamp":1747157884998,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clml.2020.11.024","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T13:56:04Z","timestamp":1611582964000},"page":"e353-e355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Regression of Marginal Zone Lymphoma After Praziquantel Therapy in a Patient With Remote Schistosoma haematobium Infection"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-7282","authenticated-orcid":false,"given":"Myint B.","family":"Thu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-978X","authenticated-orcid":false,"given":"Nyein N.","family":"Htun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khin H.H.","family":"Soe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"McKinley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7155-5586","authenticated-orcid":false,"given":"Mala","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Yoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.11.024_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3748\/wjg.v6.i1.12","article-title":"Schistosomiasis: progress and problems","volume":"6","author":"Wu","year":"2000","journal-title":"World J Gastr"},{"key":"10.1016\/j.clml.2020.11.024_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clml.2020.11.024_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.curtheres.2019.06.001","article-title":"Schistosomiasis: life-cycle, diagnosis, and control","volume":"91","author":"Nelwan","year":"2019","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.clml.2020.11.024_bib4","doi-asserted-by":"crossref","first-page":"d2651","DOI":"10.1136\/bmj.d2651","article-title":"Diagnosis and management of schistosomiasis","volume":"342","author":"Gray","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2020.11.024_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0001-706X(96)00030-7","article-title":"Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel\u2014an interim report","volume":"62","author":"Richter","year":"1996","journal-title":"Acta Trop"},{"issue":"pt B","key":"10.1016\/j.clml.2020.11.024_bib6","first-page":"1","article-title":"Biological Agents Volume 100B, A Review of Human Carcinogens","volume":"100","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.clml.2020.11.024_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4269\/ajtmh.1971.20.237","article-title":"Follicular lymphoma of the spleen in patients with hepatosplenic Schistosomiasis mansoni","volume":"20","author":"Andrade","year":"1971","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.clml.2020.11.024_bib8","first-page":"287","article-title":"Giant follicular lymphoma and Schistosomiasis mansoni","volume":"23","author":"Paes","year":"1981","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.clml.2020.11.024_bib9","first-page":"85","article-title":"Lymphoma in patients harboring hepatosplenic mansonic schistosomiasis","volume":"43","author":"Ferraz","year":"2006","journal-title":"Arq Gastr"},{"key":"10.1016\/j.clml.2020.11.024_bib10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4269\/ajtmh.2004.71.552","article-title":"Symptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma","volume":"71","author":"Montes","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.clml.2020.11.024_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ajh.25316","article-title":"Concomitant classic Hodgkin lymphoma and schistosomiasis","volume":"94","author":"Wong","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.11.024_bib12","first-page":"59","article-title":"Lymphoma and Schistosoma mansoni schistosomiasis. Report of 1 case","volume":"39","author":"Chirimwami","year":"1991","journal-title":"Arch Anat Cytol Pathol"},{"key":"10.1016\/j.clml.2020.11.024_bib13","first-page":"77","article-title":"Association of hepatosplenic Schistosomiasis mansoni and histiocytic lymphoma","volume":"19","author":"De Andrade","year":"1982","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.clml.2020.11.024_bib14","first-page":"703","article-title":"Burkitt\u2019s tumor and accompanying schistosomiasis of urogenital system","volume":"35","author":"Jakubowski","year":"1978","journal-title":"Przegl Lek"},{"key":"10.1016\/j.clml.2020.11.024_bib15","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00277-018-3561-9","article-title":"Diffuse large B cell lymphoma and schistosomiasis: a rare simultaneous occurrence","volume":"98","author":"Zanelli","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.11.024_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07102.x","article-title":"Malignant lymphoma and Schistosoma japonica infection","volume":"142","author":"Natori","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.11.024_bib17","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/jgh.12928","article-title":"Gastroenterology: hepatosplenic T cell lymphoma associated with schistosomiasis","volume":"30","author":"Azevedo","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clml.2020.11.024_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2217\/fon-2017-0480","article-title":"Effective management strategies for patients with marginal zone lymphoma","volume":"14","author":"Rosand","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.clml.2020.11.024_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1309\/MECJ-GLK1-WEBW-UEVE","article-title":"Comparative study of marginal zone lymphoma involving bone marrow","volume":"117","author":"Kent","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clml.2020.11.024_bib20","doi-asserted-by":"crossref","first-page":"e2016006","DOI":"10.4084\/mjhid.2016.006","article-title":"Infectious aetiology of marginal zone lymphoma and role of anti-infective therapy","volume":"8","author":"Perrone","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clml.2020.11.024_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-018-0687-9","article-title":"Marginal zone lymphoma: clinicopathologic variations and approaches to therapy","volume":"20","author":"Ayyappan","year":"2018","journal-title":"Curr Oncol Rep"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T06:36:13Z","timestamp":1730529373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020306662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2152265020306662"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.11.024","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regression of Marginal Zone Lymphoma After Praziquantel Therapy in a Patient With Remote Schistosoma haematobium Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}